Javascript was detected to be disabled. Javascript is required for some functions on this website.

FROM KNOWLEDGE TO SOLUTIONS

Where scientific rigor meets real-world healthcare impact

InnoValHC is an independent research institute combining scientific excellence, senior academic and industry expertise, and a trusted international expert network. We help you successfully navigate the most demanding challenges in health economics, HTA, value assessment, pricing, reimbursement, and patient access strategy.
Contact us to find out how we can best support you to convert complexity into evidence, value, and access.

Pixabay Grafik (#7562017)

Access to Rare and Complex Disease Therapies

Michael Schlander gave a presentation at the European Parliament in Brussels, Belgium, as part of the ´Health Leadership Mission for Rare Diseases´ (HLM4Rare) platform (July 01, 2026).

Read more …

Heidelberg Health Economics Summer School 2026

The Heidelberg Health Economics Summer School Basic Module took place in the picturesque setting of the Italian Dolomites (Bruneck-Brunico, June 25-27, 2026).

Read more …

German Cancer Congress (DKK) 2026

Michael Schlander was invited to contribute to the Highlight Session ´Socioeconomic Consequences of Cancer in Germany: The Perspective of Patients and their Relatives´ at the DKK in Berlin / Germany (Feb. 21, 2026).

Read more …

Financing Health Care: Structural Challenges in Germany

Article published by Michael Schlander on structural challenges in health care financing and necessary reforms in the German health care system.

Read more …

Advancing Health Economics with Scientific Integrity

We believe that health economics should serve as a bridge between medical innovation and sustainable, value-based, patient-centered healthcare systems. As an independent, highly specialized advisory team, we maintain strict scientific credibility while delivering high-impact solutions. We reject the rigid, one-size-fits-all models of traditional value analyses and instead provide objective, evidence-based insights that serve both private life science companies, public research organizations, and healthcare policy makers.

Our research service offers are designed to support our partners at every stage of the research, regulatory, and patient access challenges. Whether we are building advanced economic models for commercial therapies, delivering executive education, or participating in large European research consortia as a trusted health economics partner, our work is always anchored in scientific rigor and transparent methodology. Explore our core pillars below to see how rigorous science meets our commitment to improving patient lives and shaping a fairer healthcare system.

Selected Projects

Cost Effectiveness Thresholds (CETs)

Michael Schlander, Ramon Schaefer, Maarten Postma, Søren Holm:

Cost Effectiveness Thresholds:
Ethical Considerations and Practical Reality

Initial Findings from an Integrative Review

IV Discussion Paper No. 39
© InnoValHC, Wiesbaden 2026
ISBN 978-3-941609-38-9

Available soon here ...

Initiated research project to understand the use of thresholds in the context of CEA, considering the relevant scientific literature, WHO statements, and policy recommendation, and to bring about a more balanced perspective on the roles and limitations of cost effectiveness thresholds (CETs), contributing to worldwide dialogues on their use in the context of HTA.

The Value of Laboratory Medicine

Michael Schlander, Ramon Schäfer, Lorenz Selberg:

Nutzen der Labormedizin
in der Schweiz

Berlin, Heidelberg: Springer 2023
ISBN 978-3-662-66824-5 (Softcover)
ISBN 978-3-662-66825-2 (eBook)
https://doi.org/10.1007/978-3-662-66825-2

Open Access Book

While experts believe that 70 % of all clinical decisions depend on laboratory test information, the cost effectiveness of many diagnostic procedures is subject to controversial debate.
With this publication, we provide insight into the value of laboratory medicine from the perspectives of patients, public health, and society at large, using the Swiss health care system as a case study.